Minimal Invasive Versus Traditional Transgluteal Approach in Total Hip Arthroplasty: a Comparative Gait Analysis

The hypothesis for the present study was that patients receiving a minimally invasive total hip arthroplasty will show a faster improvement on walking ability and mobilization in the immediate postoperative period compared to patients with the standard Hardinge approach. Therefore, the main goal was to evaluate the differences in early rehabilitation of these two different surgical approaches by gait analysis and electromyographical examination as objective methods.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Total Hip Arthroplasty

Sex eligibility

All sexes

Study type

Observational

Primary location

Orthopedic Hospital Speising

Vienna, 1130, Austria

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

unilateral osteoarthritis of the hip
BMI below 30

Exclusion criteria

previous surgery on the evaluated hip,
previous arthroplasties on other joints,
a leg length discrepancy of more than 0.5cm,
rheumatoid osteoarthritis
decreased mobility due to non joint related factors

Treatment and study plan

minimally invasive total hip arthroplasty

Procedure

minimally invasive total hip arthroplasty

standard approach total hip arthroplasty

Procedure

standard Hardinge approach/traditional transgluteal approach

Sponsors and collaborators

Lead sponsor

Orthopedic Hospital Vienna Speising

Other

Registry information

Important dates

First posted: Jan 28, 2009
Registry last updated: Jan 28, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed